Literature DB >> 8512658

A kallikrein-like enzyme in human vascular tissue.

P Madeddu1, T Gherli, P P Bacciu, M Maioli, N Glorioso.   

Abstract

We attempted to identify the presence of kallikrein in human vascular tissue obtained from patients undergoing surgery. Sections of thoracic (n = 9) and abdominal aorta (n = 6), renal artery (n = 6), and saphenous vein (n = 17) were rinsed with 0.01 mol/L Tris-HCl buffer, cleaned, minced, and homogenized at 4 degrees C. The homogenates were centrifuged and supernatants were assayed for protein content and for active and total (trypsin activation) enzymatic activity on the peptide H-D-Val-Leu-Arg-paranitroanilide (S2266), a synthetic substrate for glandular kallikrein. Enzymatic activity was inhibited by aprotinin and polyclonal antibodies against human glandular kallikrein. Kallikrein was resistant to soybean trypsin inhibitor and had an optimum pH of 8.2. A significant correlation was found between the amidolytic and kininogenase activities measured on S2266 and dog kininogen, respectively (r = 0.83, P < .01). The kallikrein-like enzyme was present mainly in the inactive form. Higher levels were found in the homogenates of renal artery (active: 190 +/- 36, total: 5036 +/- 908 pkat/g protein) than in those of thoracic (active: 38 +/- 9, total: 973 +/- 350 pkat/g protein) and abdominal aorta (active: 44 +/- 10, total: 3031 +/- 709 pkat/g protein). In the homogenates of saphenous vein, active and total enzymatic activities averaged 188 +/- 90 and 2003 +/- 450 pkat/g protein, respectively. A significant inverse correlation was found between the levels of total enzymatic activity in saphenous vein homogenates and mean blood pressure values (r = 0.78, P < .005). These results suggest that a kallikrein-like enzyme is present in human vasculature.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512658     DOI: 10.1093/ajh/6.5.344

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Endothelial AT(2)-receptors: chicken or egg?

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

2.  Somatic cell gene therapy for a trait as complex as hypertension?

Authors:  J A Martinez; D T O'Connor
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.

Authors:  A Del Rosso; O Distler; A F Milia; C Emanueli; L Ibba-Manneschi; S Guiducci; M L Conforti; S Generini; A Pignone; S Gay; P Madeddu; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

4.  AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions.

Authors:  Jun Katada; Masataka Majima
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

5.  Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.

Authors:  C Wang; L Chao; J Chao
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Role of human tissue kallikrein in gastrointestinal stromal tumour invasion.

Authors:  P Dominek; P Campagnolo; M H-Zadeh; N Kränkel; M Chilosi; J A Sharman; A Caporali; G Mangialardi; G Spinetti; C Emanueli; M Pignatelli; P Madeddu
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

7.  Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse.

Authors:  C Emanueli; M Bonaria Salis; C Figueroa; J Chao; L Chao; L Gaspa; M C Capogrossi; P Madeddu
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.